Business Description
Dian Diagnostics Group Co Ltd
ISIN : CNE1000015N1
Share Class Description:
SZSE:300244: Class ACompare
Compare
Traded in other countries / regions
300244.China IPO Date
2011-07-19Description
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.43 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 9.82 | |||||
| Interest Coverage | 4.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.34 | |||||
| Beneish M-Score | -3.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | -1.6 | |||||
| 3-Year EPS without NRI Growth Rate | -26.5 | |||||
| 3-Year FCF Growth Rate | 4.2 | |||||
| 3-Year Book Growth Rate | 16.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 36.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.83 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.22 | |||||
| 9-Day RSI | 43.49 | |||||
| 14-Day RSI | 47.49 | |||||
| 6-1 Month Momentum % | -4.84 | |||||
| 12-1 Month Momentum % | -50.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 2.24 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 64.93 | |||||
| Days Sales Outstanding | 251.99 | |||||
| Days Payable | 82.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.6 | |||||
| Dividend Payout Ratio | 1.82 | |||||
| 3-Year Dividend Growth Rate | 16 | |||||
| Forward Dividend Yield % | 5.6 | |||||
| 5-Year Yield-on-Cost % | 51.08 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 21.47 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.6 | |||||
| Operating Margin % | 7.28 | |||||
| Net Margin % | -0.75 | |||||
| FCF Margin % | 8.93 | |||||
| ROE % | -1.24 | |||||
| ROA % | -0.52 | |||||
| ROIC % | 3.39 | |||||
| ROC (Joel Greenblatt) % | 4.37 | |||||
| ROCE % | 3.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 15.64 | |||||
| PE Ratio without NRI | 32.48 | |||||
| Shiller PE Ratio | 13.51 | |||||
| PEG Ratio | 2.02 | |||||
| PS Ratio | 0.66 | |||||
| PB Ratio | 1.12 | |||||
| Price-to-Tangible-Book | 1.29 | |||||
| Price-to-Free-Cash-Flow | 7.09 | |||||
| Price-to-Operating-Cash-Flow | 4.85 | |||||
| EV-to-EBIT | 25.03 | |||||
| EV-to-Forward-EBIT | 6.79 | |||||
| EV-to-EBITDA | 25.03 | |||||
| EV-to-Forward-EBITDA | 4.69 | |||||
| EV-to-Revenue | 0.83 | |||||
| EV-to-Forward-Revenue | 0.8 | |||||
| EV-to-FCF | 9.08 | |||||
| Price-to-Projected-FCF | 0.6 | |||||
| Price-to-DCF (Earnings Based) | 1.04 | |||||
| Price-to-DCF (FCF Based) | 0.61 | |||||
| Price-to-Median-PS-Value | 0.34 | |||||
| Price-to-Graham-Number | 1.37 | |||||
| Price-to-Net-Current-Asset-Value | 2.87 | |||||
| Earnings Yield (Greenblatt) % | 4 | |||||
| FCF Yield % | 13.92 | |||||
| Forward Rate of Return (Yacktman) % | -2.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dian Diagnostics Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 12,374.236 | ||
| EPS (TTM) (Â¥) | -0.143 | ||
| Beta | 1.24 | ||
| Volatility % | 59.77 | ||
| 14-Day RSI | 47.49 | ||
| 14-Day ATR (Â¥) | 0.592259 | ||
| 20-Day SMA (Â¥) | 13.181 | ||
| 12-1 Month Momentum % | -50.33 | ||
| 52-Week Range (Â¥) | 8.9 - 27.35 | ||
| Shares Outstanding (Mil) | 624.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dian Diagnostics Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dian Diagnostics Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dian Diagnostics Group Co Ltd Frequently Asked Questions
What is Dian Diagnostics Group Co Ltd(SZSE:300244)'s stock price today?
The current price of SZSE:300244 is ¥12.70. The 52 week high of SZSE:300244 is ¥27.35 and 52 week low is ¥8.90.
When is next earnings date of Dian Diagnostics Group Co Ltd(SZSE:300244)?
The next earnings date of Dian Diagnostics Group Co Ltd(SZSE:300244) is .
Does Dian Diagnostics Group Co Ltd(SZSE:300244) pay dividends? If so, how much?
The Dividend Yield %  of Dian Diagnostics Group Co Ltd(SZSE:300244) is 5.6% (As of Today), Highest Dividend Payout Ratio of Dian Diagnostics Group Co Ltd(SZSE:300244) was 1.82. The lowest was 0.04. And the median was 0.09. The  Forward Dividend Yield % of Dian Diagnostics Group Co Ltd(SZSE:300244) is 5.6%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers